Turan, B. 2022. Comparisons of pleiotropic-effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction. Advances in Cardiıvascular Science and Medicine Through Diversity, Equity, and Inclusion Supported by Education, Research, and Technology Innovation , (Winnipeg, Canada).

Turan, B., (2022). Comparisons of pleiotropic-effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction . Advances in Cardiıvascular Science and Medicine Through Diversity, Equity, and Inclusion Supported by Education, Research, and Technology Innovation, Winnipeg, Canada

Turan, BELMA. "Comparisons of pleiotropic-effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction," Advances in Cardiıvascular Science and Medicine Through Diversity, Equity, and Inclusion Supported by Education, Research, and Technology Innovation, Winnipeg, Canada, 2022

Turan, BELMA. "Comparisons of pleiotropic-effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction." Advances in Cardiıvascular Science and Medicine Through Diversity, Equity, and Inclusion Supported by Education, Research, and Technology Innovation , Winnipeg, Canada, 2022

Turan, B. (2022) . "Comparisons of pleiotropic-effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction." Advances in Cardiıvascular Science and Medicine Through Diversity, Equity, and Inclusion Supported by Education, Research, and Technology Innovation , Winnipeg, Canada.

@conferencepaper{conferencepaper, author={BELMA TURAN}, title={Comparisons of pleiotropic-effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction}, congress name={Advances in Cardiıvascular Science and Medicine Through Diversity, Equity, and Inclusion Supported by Education, Research, and Technology Innovation}, city={Winnipeg}, country={Canada}, year={2022}}